ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Hafssa El Hilali, Nassiba Bahra, Sanae Guennouni, Chaymae Chbihi, Samia El Hakym, Diango Keita, Sara Nejjari, Abir Oufrid, Oumaima Siyouri, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Touria Bouhafa, Nawfel Mellas, Samira El Fakir, Samia Arifi
Bincy Mathew, Nitin Yashas Murthy, Amit Rauthan, Poonam Patil, Devesh Ballal, Shabber S Zaveri, Guddahatty Nanjappa Hemanth, Ananthakrishnan Nidheesh, Nidudi Javaregowda Harshitha
Alfred Jatho, Sheba Nakacubo Gitta, Vincent K Kalungi, Ronald Opito, Samuel Okello, Robinah Komuhendo, James Kafeero, Noleb Mugisha
Hugo Castro-Salguero, Bremilin Ramírez-Najarro, Jorge Tello-Mérida, Lourdes Castro-Salazar, Luis García-Aceituno